ASCRS 2025: Companies share preview of data and presentations scheduled for 2025 annual meeting

(Image credit: AdobeStock/Andy)

The Ophthalmology Times team is onsite at American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting 2025. This 4-day conference begins of April 25 and runs through April 28, 2025, in Los Angeles, California. The meeting will cover the latest developments and innovations in anterior segment surgery, and many companies will be onsite presenting data and research.

Note: The following list of presentations are in alphabetical order by company. Updates will be added to this article as new information becomes available.

Ace Vision Group

Several presentations at the ASCRS 2025 will showcase the company’s latest clinical advancements and novel research in laser scleral microporation – a minimally invasive treatment designed to restore natural Dynamic Range of Focus (DRoF) in presbyopic patients. The company’s participation highlights its continued leadership in the development of non-lens-based solutions for aging-related vision loss.¹

EyeCare Partners

In an announcement, EyeCare Partners shared that more than 12 of their doctors from across the United States are scheduled to conduct learning sessions, presentations, and instruction courses at the 2025 ASCRS meeting. These presentations will highlight advancements in digital surgical tools, artificial iris implants and telehealth follow-ups after cataract surgery, among other timely topics.²

Glaukos Corporation

The company’s therapies and technologies will be featured throughout the presentations. The announcement from Glaukos included 10 scheduled presentations from several researchers and key opinion leaders including Fritz Hengerer, MD, Zachary Vest, MD, Inder Singh, MD, Savek Teymoorian, MD, John Berdahl, MD, Weijie Lin, MD, Maanasa Indaram, MD, Vance Thompson MD, and George Wandling, MD.³

Johnson & Johnson

Johnson & Johnson will present data supporting the performance of the next-generation TECNIS Odyssey IOL at the 2025 ASCRS Annual Meeting. Four of the 22 company sponsored and investigator led studies report excellent visual outcomes at every distance, minimized dysphotopsias, and high spectacle independence with TECNIS Odyssey IOL, further supporting the product's position as the fasting growing PCIOL in the US market. Additional research being presented also reports positive visual and refractive outcomes associated with TECNIS Eyhance, and suggests that TECNIS Symfony OptiBlue provides mild glaucoma patients the opportunity to enjoy good vision at all distances.⁴

MicroSurgical Technology

MicroSurgical Technology will share research during 2 presentations on the Vista 1-Step novel vitrectomy probe at the 2025 ASCRS Annual Meeting. The Vista 1-Step, a 27-gauge, 14.5 mm needlepoint single-use vitrector, is designed for a seamless introduction through the sclera. Featuring a dual-blade cutter, it delivers up to 11,000 cuts per minute, connects directly to all major phaco/posterior units, and is intended to be used to remove vitreous and dissect the eye.⁵

• Safety and Performance of a 27-Gauge, 22,000-Cut-per-Minute Vitrectomy Probe for Pars Plana Anterior Vitrectomy
  Presented by Brandon D. Ayres, MD, ABO, on April 26, 2025, from 8:38-8:43 AM PT
• Safety and Efficacy Outcomes of a Novel Vitrectomy Device Used to Remove Symptomatic Vitreous Opacities in Pseudophakic Patients
  Presented by Inder P. Singh, MD, on April 27, 2025, from 8:30-8:35 AM PT

Nextech

The company plans to preview the latest enhancements to its integrated optical software, part of a recently announced partnership with Ocuco. This system incorporates enhanced documentation to enable more personalized patient consultations while an artificial intelligence (AI)-driven scribe uses ambient listening to automatically complete charting in real time. It is designed to streamline patient acquisition and retention and manage patient relationships with customer relationship management (CRM) technology tailored for eyecare practices. The system can also improve coordination with your ASC by facilitating information exchange between a practice and the ambulatory surgery center and to close gaps in the continuity of care.⁶

Nordic Pharma

At the ASCRS 2025 Annual Meeting, Nordic Pharma will present recently published patient data and patient experience study for LACRIFILLCanalicular Gel, a novel therapy for dry eye symptoms. This comes 1 year after launching at ASCRS 2024. The company says that it now has case studies and patient experience data from MDs and ODs showing how LACRIFILL Canalicular Gel is impacting practices and patients.⁷

Sight Sciences

Sight Sciences will debut the expansion of the OMNI® product family by launching the OMNI Edge Surgical System. The introduction of OMNI Edge expands the OMNI product family while maintaining the availability of OMNI, ensuring surgeons have access to both technologies to meet their unique surgical preferences and patient needs. OMNI Edge is only available in the United States.⁸

SpyGlass Pharma

A poster presentation at ASCRS 2025 will highlight the 18-month data from the first-in-human study of the SpyGlass Drug Delivery Platform, which demonstrated improvements in both visual acuity and intraocular pressure (IOP) outcomes, key objectives for long-term treatment of glaucoma or ocular hypertension.⁹

Tarsus

Tarsus Pharmaceuticals, Inc. will present 4 distinct data sets highlighting the global prevalence and real-world patient burden of Demodex blepharitis, as well as the impact of XDEMVY (lotilaner ophthalmic solution) 0.25% in addressing objective measures of disease.¹⁰

ZEISS

The company will present new research abstracts that showcase the refractive accuracy and clinical outcomes when adopting the ZEISS Cataract Workflow:

Steven C. Schallhorn, MD, ABO, will present on the benefit of reducing postoperative astigmatism by implanting toric IOLs in patients with lower preoperative corneal astigmatism, leveraging cataract outcomes obtained from VERACITY Surgery Planner's database of 50,850 eyes with preoperative corneal astigmatism between 0.75D and 1.50D.

Luke Rebenitsch, MD, ABO, will share a comparison of refractive outcomes in a large cohort of 49,057 eyes undergoing cataract surgery with toric IOL implantation where the use of the ZEISS CALLISTO eye system resulted in significant improvements in terms of post-op refractive outcomes compared to a manual marking approach.

Kamran M. Riaz, MD, ABO, will give a presentation on an analysis of the refractive accuracy of two biometers in a cohort of 222 eyes with prior laser vision correction and implantation of toric multifocal IOLs, highlighting the significantly better performance of total keratometry with the IOLMaster 700.¹¹

References:

1. Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting. Ace Vision Group, Inc. April 10, 2025. Accessed April 25, 2025. https://www.globenewswire.com/news-release/2025/04/10/3059206/0/en/Ace-Vision-Group-to-Host-Take-the-Presbyopia-Challenge-Event-and-Present-Scientific-Posters-at-2025-ASCRS-Annual-Meeting.html

2. EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles. EyeCare Partners. April 23, 2025. Accessed April 25, 2025. https://www.businesswire.com/news/home/20250423321460/en/EyeCare-Partners-Presents-Latest-Innovations-in-Eye-Care-at-the-American-Society-of-Cataract-and-Refractive-Surgery-ASCRS-2025-in-Los-Angeles

3. Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. Glaukos Corporation. April 23, 2025. Accessed April 25, 2025. https://www.businesswire.com/news/home/20250423498462/en/Glaukos-to-Present-Multiple-Scientific-Abstracts-at-the-2025-American-Society-of-Cataract-and-Refractive-Surgery-ASCRS-Annual-Meeting

4. Johnson & Johnson to Present New Data for TECNIS Odyssey, The Fastest Growing PCIOL in the U.S^, at ASCRS 2025. Johnson & Johnson MedTech. April 25, 2025. Accessed April 25, 2025. https://www.prnewswire.com/news-releases/johnson--johnson-to-present-new-data-for-tecnis-odyssey-the-fastest-growing-pciol-in-the-us-at-ascrs-2025-302438074.html

5. MicroSurgical Technology (MST) Advances Leadership in Vitrectomy Technology with Presentations at ASCRS 2025 Annual Meeting. MicroSurgical Technology. April 22, 2025. Accessed April 25, 2025. https://www.prnewswire.com/news-releases/microsurgical-technology-mst-advances-leadership-in-vitrectomy-technology-with-presentations-at-ascrs-2025-annual-meeting-302434009.html

6. Nextech to Unveil Powerful Eyecare Innovations at ASCRS Annual Meeting. Nextech Systems, Inc. April 25, 2025. Accessed April 25, 2025. https://www.globenewswire.com/news-release/2025/04/25/3068324/0/en/Nextech-to-Unveil-Powerful-Eyecare-Innovations-at-ASCRS-Annual-Meeting.html

7. Nordic group b.v. through its subsidiary nordic pharma, inc. (u.s.), presenting patient data and patient experience study for lacrifill® canalicular gel, a novel therapy for dry eye, at the american society of cataract and refractive surgery annual meeting. Nordic Pharma. April 23, 2025. Accessed April 25, 2025. https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-presenting-patient-data-and-patient-experience-study-for-lacrifill-canalicular-gel-a-novel-therapy-for-dry-eye-at-the-american-society-of-cataract-and-refract-302435031.html

8. Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio. Sight Sciences, Inc. April 21, 2025. Accessed April 25, 2025. https://www.globenewswire.com/news-release/2025/04/21/3064976/0/en/Sight-Sciences-to-Debut-OMNI-Edge-Surgical-System-at-the-2025-ASCRS-Annual-Meeting-Expanding-the-OMNI-Product-Portfolio.html

9. SpyGlass Pharma Presents 18-Month Data Demonstrating Compelling Visual Acuity Results with Their IOL-mounted Innovative Drug Delivery Platform. SpyGlass Pharma. April 24, 2025. Accessed April 25, 2025. https://www.globenewswire.com/news-release/2025/04/24/3067371/0/en/SpyGlass-Pharma-Presents-18-Month-Data-Demonstrating-Compelling-Visual-Acuity-Results-with-Their-IOL-mounted-Innovative-Drug-Delivery-Platform.html

10. Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting. Tarsus Pharmaceuticals, Inc. April 22, 2025. Accessed April 25, 2025. https://www.globenewswire.com/news-release/2025/04/22/3065511/0/en/Tarsus-to-Present-Several-Scientific-Abstracts-Highlighting-the-Global-Prevalence-of-Demodex-Blepharitis-and-the-Clinical-Impact-of-XDEMVY-at-the-American-Society-of-Cataract-and-R.html

11. ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone. Carl Zeiss Meditec AG. April 17, 2025. Accessed April 25, 2025. https://www.prnewswire.com/in/news-releases/zeiss-continues-to-drive-digital-era-forward-in-ophthalmology-celebrates-2-million-digitally-planned-cataract-cases-in-the-us-alone-302431074.html